Latest multiple sclerosis News | Page 2

Mode Medical Pty Ltd and executive officer fined almost $160,000 for alleged unlawful advertising of intravenous infusion products
Obesity linked to macular degeneration
Immune cells help protect brain health and cognition
2022 Betty McGrath Seeding Grant Winners
Netflix psychiatrist Phil Stutz says 85% of early therapy gains are down to lifestyle changes
Celebrating people with disability within Queensland Police Service
Chris Hemsworth’s Alzheimer’s gene doesn’t guarantee he’ll develop dementia
New precinct and homes for Lidcombe
Big data used to identify existing drugs that could be repurposed for broader medical applications
Changing treatment can help MS patients: study
NSW police remind motorists of road closures ahead of 40th MS Sydney to Gong charity bike ride
Ultomiris showed zero relapses in adults with neuromyelitis optica spectrum disorder with median treatment duration of
Alexion aims to advance NMOSD treatment landscape with exceptional Ultomiris efficacy data at ECTRIMS 2022
Major ANU funding win to boost health for all Australians
Penrith celebrates 30 years of Council’s Access Committee
‘They treat you like a person, they ask you what you want’: what NDIS participants value in support workers
Treatment offers new hope for lupus – and maybe for other autoimmune diseases too
Long COVID inquiry encouraging, but more work needed on how to treat patients
Cells help immune system tolerate friendly gut bacteria
Covid oral treatments
What allegations of Alzheimer’s research fraud mean for patients
PBS Listings will help people with spinal muscular atrophy, schizophrenia and multiple sclerosis
Multiple sclerosis diagnosis hasn’t stopped footballer kicking goals
Finding triggers of inflammation
NeuroScientific Biopharmaceuticals seeks approval for phase 1 trial
Academic-industry partnership aims to lower cost of cultivated meat
Four Curtin researchers recognised in 2022 WA Young Tall Poppy Awards
NeuroScientific Biopharmaceuticals reports positive data from animal study
New Changing Place supporting Fremantle locals and visitors with disability
Government response to independent Pharmac Review
NeuroScientific Biopharmaceuticals submits for approval of early-phase trial
Ultomiris met primary endpoint in CHAMPION-NMOSD Phase III trial
How Herpesviruses Awaken
Hitting nerve: how antidepressants treat nerve pain
Findings open way for personalised MS treatment
Australia’s Post-viral Disease Tsunami Threat
Could releasing ‘handbrake’ immune cells help supercharge immunity?
Artificial Intelligence research project winner in $2.1 million funding program
University of Sydney rises in QS subject rankings
Nine out of 10 Aussies have low vitamin D intakes, Curtin study shows
AstraZeneca’s antibody combination, Evusheld▼ authorised for use
Discovery may help reduce side effects of MS drugs
From driveways to mRNA, startup founders bolster University of Toronto’s rapid rise in entrepreneurship space
Survivors of code red condition offer hope as half of those with Covid experience signs similar to brain injury
Researchers use diet to fight multiple sclerosis
Medicinal cannabis in sport: An insight for athletes and support people
Funding support to discover ways to block migration of T-cells responsible for MS
‘Boot camp’ enzyme prevents autoimmune conditions